Granular boosts mast cell disease programme
Therapy candidates chosen for lead projects targeting mast cell driven diseases
Read More
Tag: disease
Positive results from Poolbeg Pharma’s human challenge trial
Candidate POLB 001 demonstrates potential in treating multiple influenza conditions
Read More
AZ commits £28m to tackle non-communicable disease
The plan is designed to inform adolescents in under-resourced communities on how to reduce risky behaviours including smoking, alcohol, poor diet and lack of exercise.
Read More
Takeda acquires investigational coeliac therapy
The Japanese pharma giant acquired the drug based on results from a phase IIa trial, in which the drug met its primary endpoint.
Read More
‘Innovative’ new disease and infection test
Queen’s University researchers have developed a new test to detect disease and infection that could save time, money and possibly lives.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
